These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 19377242

  • 1. Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.
    Einollahi B, Lessan-Pezeshki M, Nourbala MH, Simforoosh N, Pourfarziani V, Nemati E, Nafar M, Basiri A, Pour-Reza-Gholi F, Firoozan A, Ghadiani MH, Makhdoomi K, Ghafari A, Ahmadpour P, Oliaei F, Ardalan MR, Makhlough A, Samimagham HR, Azmandian J, Razeghi E, Shahbazian H.
    Iran J Kidney Dis; 2008 Oct; 2(4):227-33. PubMed ID: 19377242
    [Abstract] [Full Text] [Related]

  • 2. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 3. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 4. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA, Prendeville S, McCaughan JA, Traynor C, OʼBrien FJ, Ward FL, OʼDonovan D, Kennedy C, Berzan E, Kinsella S, Williams Y, OʼKelly P, Deady S, Comber H, Leader M, Conlon PJ.
    Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
    [Abstract] [Full Text] [Related]

  • 5. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 6. Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.
    Funch DP, Ko HH, Travasso J, Brady J, Kew CE, Nalesnik MA, Walker AM.
    Transplantation; 2005 Nov 15; 80(9):1174-80. PubMed ID: 16314782
    [Abstract] [Full Text] [Related]

  • 7. Lymphoma after living donor kidney transplantation: an Iranian multicenter experience.
    Pourfarziani V, Taheri S, Lessan-Pezeshki M, Nourbala MH, Simforoosh N, Nemati E, Makhdoomi K, Ghafari A, Ahmadpour P, Nafar M, Einollahi B.
    Int Urol Nephrol; 2008 Nov 15; 40(4):1089-94. PubMed ID: 18592392
    [Abstract] [Full Text] [Related]

  • 8. Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.
    Khedmat H, Taheri S.
    Hematol Oncol Stem Cell Ther; 2011 Nov 15; 4(2):73-80. PubMed ID: 21727768
    [Abstract] [Full Text] [Related]

  • 9. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, Kluin PM, Kluin-Nelemans HC.
    Clin Transplant; 2005 Jun 15; 19(3):327-34. PubMed ID: 15877793
    [Abstract] [Full Text] [Related]

  • 10. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
    Khedmat H, Taheri S.
    Ann Transplant; 2010 Jun 15; 15(3):80-6. PubMed ID: 20877272
    [Abstract] [Full Text] [Related]

  • 11. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
    Arita H, Izumoto S, Kinoshita M, Okita Y, Hashimoto N, Fujita T, Ichimaru N, Takahara S, Yoshimine T.
    Neurol Med Chir (Tokyo); 2010 Jun 15; 50(12):1079-83. PubMed ID: 21206182
    [Abstract] [Full Text] [Related]

  • 12. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S, Debray D, Delarue A, Deschênes G.
    Pediatr Nephrol; 2002 Aug 15; 17(8):668-72. PubMed ID: 12185479
    [Abstract] [Full Text] [Related]

  • 13. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
    Khedmat H, Taheri S.
    Exp Clin Transplant; 2011 Aug 15; 9(4):258-64. PubMed ID: 21819371
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
    Birkeland SA, Hamilton-Dutoit S, Bendtzen K.
    Transplantation; 2003 Jul 15; 76(1):153-8. PubMed ID: 12865802
    [Abstract] [Full Text] [Related]

  • 15. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
    Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW.
    Transplantation; 2003 Nov 15; 76(9):1289-93. PubMed ID: 14627905
    [Abstract] [Full Text] [Related]

  • 16. Heterogeneous Manifestations of Posttransplant Lymphoma in Renal Transplant Recipients: A Case Series.
    Patil R, Prashar R, Patel A.
    Transplant Proc; 2021 Jun 15; 53(5):1519-1527. PubMed ID: 34134932
    [Abstract] [Full Text] [Related]

  • 17. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?
    Birkeland SA, Hamilton-Dutoit S.
    Transplantation; 2003 Sep 27; 76(6):984-8. PubMed ID: 14508366
    [Abstract] [Full Text] [Related]

  • 18. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience.
    Wójciak M, Gozdowska J, Dęborska-Materkowska D, Perkowska-Ptasińska A, Kosieradzki M, Nazarewski S, Durlik M.
    Transplant Proc; 2018 Sep 27; 50(7):2154-2158. PubMed ID: 30177129
    [Abstract] [Full Text] [Related]

  • 19. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T, Zwick DL, Rothberg PG, Warady BA.
    Pediatr Nephrol; 1999 Nov 27; 13(9):748-54. PubMed ID: 10603113
    [Abstract] [Full Text] [Related]

  • 20. Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients.
    Smith JM, Corey L, Healey PJ, Davis CL, McDonald RA.
    Transplantation; 2007 Jun 15; 83(11):1423-8. PubMed ID: 17565314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.